These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [THE OFFICIAL HAND BOOK FOR ALLERGEN IMMUNOTHERAPY IN MITE-ALLERGY - CAUSAL TREATMENT FOR PERENNIAL ALLERGIC AIRWAY DISEASES]. Nagata M Arerugi; 2016 Jul; 65(7):908-12. PubMed ID: 27545055 [No Abstract] [Full Text] [Related]
5. Efficacy of desensitization via the sublingual route in mite allergy. Guez S Chem Immunol Allergy; 2003; 82():62-76. PubMed ID: 12947993 [TBL] [Abstract][Full Text] [Related]
6. What should drive the choice of allergen for immunotherapy in polysensitized patients? Ciprandi G; Incorvaia C; Puccinelli P; Dell'Albani I; Frati F Ann Allergy Asthma Immunol; 2012 Aug; 109(2):148-9. PubMed ID: 22840259 [No Abstract] [Full Text] [Related]
7. Sublingual immunotherapy: other indications. Passalacqua G; Compalati E; Canonica GW Immunol Allergy Clin North Am; 2011 May; 31(2):279-87, ix. PubMed ID: 21530820 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic aspects in house dust mite allergy. Mosbech H Dan Med Bull; 1991 Oct; 38(5):390-400. PubMed ID: 1802624 [No Abstract] [Full Text] [Related]
9. A review of allergoid immunotherapy: is cat allergy a suitable target? Nguyen NT; Raskopf E; Shah-Hosseini K; Zadoyan G; Mösges R Immunotherapy; 2016; 8(3):331-49. PubMed ID: 26860435 [TBL] [Abstract][Full Text] [Related]
10. Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy. van de Veen W; Wirz OF; Globinska A; Akdis M Curr Opin Immunol; 2017 Oct; 48():74-81. PubMed ID: 28888176 [TBL] [Abstract][Full Text] [Related]
11. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens. Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813 [TBL] [Abstract][Full Text] [Related]
12. Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy. Takai T; Yokota T; Yasue M; Nishiyama C; Yuuki T; Mori A; Okudaira H; Okumura Y Nat Biotechnol; 1997 Aug; 15(8):754-8. PubMed ID: 9255789 [TBL] [Abstract][Full Text] [Related]
13. Preparing and mixing allergen vaccines for subcutaneous immunotherapy. Nelson HS Clin Allergy Immunol; 2008; 21():303-20. PubMed ID: 18828513 [No Abstract] [Full Text] [Related]
14. Mechanisms of Subcutaneous and Sublingual Aeroallergen Immunotherapy: What Is New? Komlósi ZI; Kovács N; Sokolowska M; van de Veen W; Akdis M; Akdis CA Immunol Allergy Clin North Am; 2020 Feb; 40(1):1-14. PubMed ID: 31761112 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Aeroallergen Immunotherapy: Subcutaneous Immunotherapy and Sublingual Immunotherapy. Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA Immunol Allergy Clin North Am; 2016 Feb; 36(1):71-86. PubMed ID: 26617228 [TBL] [Abstract][Full Text] [Related]
17. [Molecular-allergological aspects of allergen-specific immunotherapy]. Jappe U Hautarzt; 2017 Apr; 68(4):271-281. PubMed ID: 28293695 [TBL] [Abstract][Full Text] [Related]
18. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes. Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088 [TBL] [Abstract][Full Text] [Related]
19. [THE OFFICIAL MANUAL BOOK ON ALLERGEN-IMMUNOTHERAPY IN HOUSE-DUST-MITE ALLERGY]. Nagata M Arerugi; 2019; 68(3):146-150. PubMed ID: 31105110 [No Abstract] [Full Text] [Related]